Martin Capital Advisors LLP Purchases 201 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Martin Capital Advisors LLP grew its holdings in U.S. Physical Therapy, Inc. (NYSE:USPHFree Report) by 1.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,138 shares of the company’s stock after purchasing an additional 201 shares during the quarter. Martin Capital Advisors LLP owned about 0.09% of U.S. Physical Therapy worth $1,112,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in USPH. Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy during the second quarter valued at about $28,000. Innealta Capital LLC bought a new position in U.S. Physical Therapy during the second quarter valued at about $30,000. Quest Partners LLC raised its holdings in U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after acquiring an additional 337 shares in the last quarter. Northwest Bank & Trust Co bought a new stake in shares of U.S. Physical Therapy in the 4th quarter worth approximately $37,000. Finally, Quarry LP lifted its position in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after acquiring an additional 478 shares during the period.

Analysts Set New Price Targets

Several brokerages recently commented on USPH. Bank of America reaffirmed a “neutral” rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Barrington Research restated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research note on Wednesday, October 9th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.

View Our Latest Analysis on USPH

Insider Buying and Selling

In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average price of $86.09 per share, with a total value of $172,180.00. Following the transaction, the director now owns 18,904 shares in the company, valued at $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Stock Up 3.6 %

USPH opened at $80.29 on Monday. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 65.28, a PEG ratio of 3.68 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The firm’s 50-day simple moving average is $84.09 and its 200-day simple moving average is $94.18. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The firm had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.76 EPS. Equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were issued a $0.44 dividend. The ex-dividend date was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.19%. U.S. Physical Therapy’s dividend payout ratio is 143.09%.

About U.S. Physical Therapy

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHFree Report).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.